MAPK14 and familial dilated cardiomyopathy: This indicates that low-dose Celastrol may also have a modest effect on the expression of the P38 MAPK gene in the myocardial tissue of DCM to some extent, suggesting a novel target for intervention in the energetic remodeling of DCM and progression of the disease.